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   The pathogenesis of human glomerulonephritis has not been throughly 
recognized in spite of many extensive experimental examinations and clin-
ical observations. With regard to experimental glomerulonephritis, MASUGI's 
nephritis and glomerulonephritis in serum sickness has been believed to play 
an important role. In serum sickness, glomerulonephritis develops during 
the immune phase of antigen elimination, and antigen-antibody complexes 
play an important role in the pathogenesis of glomerulonephritis and vas-
cular lesions. It has been also reported that an aminonucleoside, 6-dimethy-
lamino, 3-amino-d-ribose, increased permeability of the glomerular basement 
membrane for protein. In the present study pretreated rats with aminonu-
cleoside received smaller amount of soluble antigen-antibody complexes in 
antigen excess which were produced in vitro between BSA anti-BSA rat
serum　 or　human　 γ-gl.　 anti-human　 γ-gl.　 rabbit　 serum.　 Glomerulonephritis
developed in a short time after administration of immune complexes.
                  INTRODUCTION 
   The pathogenesis of experimetal serum sickness has been extensi-
vely investigated since RICH and GREGORY described the characteristic 
lesions, glomerulonephritis, arteritis and endocarditis.1)2)3)4) 
   GERMUTH5) showed, by careful analysis of the immunologic events 
as related to the histologic alterations, that the lesions developed dur-
ing the immune phase of antigen elimination and regressed when free 
antigen appeared in the circulation. The immune phase of antigen 
elimination was of short duration and was associated with presence of 
soluble antigen-antibody complexes in the circulation. The important 
role of these antigen-antibody complexes in the pathogenesis of a cer-
tain hypersensitive state has only recently been recognized. It has been
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shown that they can produce anaphylaxis in guinea pigs6)') and mice,), 
contraction of isolated guinea pig smooth muscle 9) and inflammatory 
changes in the skin.10) More direct evidence for the role of soluble 
antigen-antibody complexes in the pathogenesis of serum sickness was 
produced by the fact that the characteristic lesions of serum sickness 
were produced by intravenous injection of a large amount of soluble 
antigen-antibody complexes in normal mice. 11)12) 
   Recently an experimental disease resembling human nephrosis has 
been produced in rats by the subcutaneous injection of an amino-
nucleoside. 13)14) 
   During the early stage of the disorder by aminonucleoside, no dete-
ctable glomerular lesions can be seen under light microscopy. 
   In the present study, experimental glomerulonephritis was produced 
passively in rats by the intravenous injection of a smaller amount of 
soluble antigen-antibody complexes than has been used in previous 
experiments within 7 days after the previous subcutaneous injection of 
aminonucleoside. 
               MATERIAL and METHOD 
   Animals: Male rats of the Wister strain with initial body weight of 
100 to 150 gm. were used. They were given free access to a commer-
cial pellet diet (MF Oriental Yeast Mfg., Tokyo) and tap water. 
Antigens: Human ;r-globulin (H . G . G .) were obtained from Midori Ju ji 
Co., Osaka, and crystallized bovine serum albumin (BSA) from Armour 
Pharmaceutical Co., Kankakkee Illinois, USA. 
Antiserums: These were produced in white male rabbits weighing 2kg. 
against H . G . G . , and in Wister male rats weighing 100 gm. against 
BSA. Each rabbit received multiple subcutaneous injections of 50 mg. 
of H . G . G . incorporated with complete Freund' s ad juvant (latron Labor-
atories). Four months after this they were given a booster injection of 
antigen. The rats were immunized against BSA (10 mg. of antigen) 
by the same method and were given a booster injection of antigen four 
weeks after the multiple injections. Both the rabbits and the rats were 
bled on the 7th day after the booster injection. 
   The protein level of the samples was measured using a hand protein 
refractometer (Hitachi). Each antiserum sample was distilled up to one 
per cent with isotonic saline solution. 
Soluble complexes: The equivalent point was examined by DEEN-WEBB'S 
method. Four times excess antigen, each antigen containing 10 mg. of 
protein in one ml., was added to the antiserum. No precipitation was 
found. The concentration of antigen and antibody protein was stand-
ardized at 10 mg. in 1 ml., so that 1 ml. contained 10 mg. of soludle 
complexes. 
Aminonucleoside (AN) : This was obtained from Nutritional Biochemi-
cals Corporation, Cleveland, Ohio. Rats received a daily subcutaneous 
injection of AN, (0.3 ml. of 0.5 per cent solution per 100 gm. of body 
weight). 
Urinary protein: This was estimated by dipping the end of an 
Albustix and comparing the color with six color standards representing 
the following concentration of urinary protein; 0(-), tr, 30(+), 100 
(+ +), 300(+ + +) and over 1000 mg. (+ + + +) protein per 100 ml. 
of urine. Some of the urinary specimens were pooled over night for 
immunoelectrophoretic study. 
Immunoelectrophoretic study: First, zone electrophoresis of the antigens 
(urine specimen and serum) was carried out for a period of 50 minutes 
in veronal buffer (pH 8.6, ,u=0.06) using a current of 0.8 milli Amp. 
per cm. width of cellulose acetate filter paper. Strips of filter paper 
with a standard length of 6 cm. and viriable width of 1 or 2 cm. were 
used. Antibody (anti-rat serum rabbit antibody and anti-BSA rabbit 
antibody) was placed on the empty half of the acetate filter paper along 
with the antigen, and then the paper was placed in liquid paraffin 
for 24 hours. The reaction between antigen and antibody was studied 
using Panceau 3R in staining. 
   Table I describes the number of experimental rats and the experi-
mental procedure followed in each of the three main groups and also 
in the subgroups. 
   The experimental animals, as a rule, were sacrificed by bleeding 
from the abdominal aorta, after being anesthelized with ether. Some 
of these were used for perfusion fixation with isotonic 1 per cent glu-
                   Table I 
        Number Total Does Interval Time of Sacri-
Number of AN of Sol. between fice after the Experimental Urinary Protein
Group of Rats Inj.* Complexes Inj. Last Inj. Period at Sacrifice 
j 3 7 - - 1 day 8 days (+)-(++) 
I[ (1)** 12 0 3 ml. 12 hrs. 3 days 4~2 days (.'_)-(+) 
  (2)*** 6 0 3 ml. 12 hrs. 3 days 4.2 days (-)-(+) 
  (1)** a 10 1-3 3 ml. 12 hrs. 3 days 5~2- 732 days +) 
       b 7 4-5 3 ml. 12 hrs. 3 days 8~2- 9~2 days (+)-(++) 
       c 11 6-7 3 ml. 12 hrs. 3 days 10.2-112 days (++++) 
       d 2 7 7 ml. 3 days 3 days 31 days (+ + +) -
  (2)***a 5 7 3 ml. 12 hrs. 3 days 11j. days (+++)-
       b 2 7 3 ml. 12 hrs. 7 days 1532 days (+++)-
 *Rats recived daily subcutaneous injections of aminonucleoside (AN) 0 .3 ml. of 0.5% 
  solution per 100 gm. of body weight. 
**Rats in Group II (1) and Group III (1) received homologous soluble complexes . 
***Rats in group II (2) and Group III (2) received heterologous soluble complexes ,
talaldeheide. 
Tissue: The kidney and other organs were sectioned after measuring 
weight and fixed in neutralized formalin and Zenker's solution. Some 
of the rats were fixed using a perfusion technique with 1 per cent 
glutalaldeheide. H.E., PAS, and PAM were used for staining. 
                     RESULTS 
Urinary protein: Protein was either absent or present in only trace 
amounts in the urine of normal rats. The urinary protein excretion of 
the rats which was treated with AN for 1 to 3 days, indicated (-) to 
(±), for 4 to 5 days, (±) to (+) and for 6 to 7 days indicated (+) 
to (++). The rats which received injections of heterologous or hom-
ologous soluble complexes after treatment with AN for 6 to 7 days 
showed a rapid increase in urinary protein on the third day after the 
last injection of soluble complexes. (Fig. 1) However, the animals
which received injections of soluble complexes after treatment with AN 
for 5 days had the same urinary protein content as the animals treated 
only with AN. Rats which received soluble complexes alone excreated 
mostly urine with a low protein content. 
Organ weight per 100 gm. of body weight: The weights of the kid-
neys and hearts of the 9 rats in group II were measured. The mean 
weight of the kidneys was 0.87 gm. and that of the hearts was 0.45 
gm. In group III (1) a, the mean weight of the kidneys was 0.81 gm. 
and that of the hearts was 0.35 gm.; in group III (1) b, the mean 
weight of the kidneys was 0.90 gm. and that of the hearts was 0.46 
gm.; and in group III (1) c, the mean weight of the kidneys was 1.05 
gm. and that of the hearts was 0.50 gm. The mean weights of the 
kidneys and hearts in group III (1) c were significantly heavier than 
the mean weights in other groups.
Immunoerectrophoretic result: BSA was noted in all sera of group 
III (1) a, b and c. The urine specimens of group III (1) c showed 
a high protein content. In addition, the presence of BSA was demon-
strated immunologically, and multiple reaction lines were noted between 
the anti-rat serum rabbit antibody and urine specimen (Fig 2). How-
ever, in the urine of group III (1) a and b indicating low grade prote-
inuria BSA was not demonstrated, and only one line was noted between 
anti-rat serum rabbit antibody and urine specimen (Fig 3). 
Light microscopic observation: None of the rats in groups I and II 
showed any pathologic alterations. The accumulation of granular eosin-
ophilic, PSA-positive materials in the cytoplasm of glomerular epithelial 
cells in AN traeted rats was not different from that of normal, untr-
eated rats. (Fig 4). Acute glomerulonephritis developed in all rats of 
group III (1) c and III (2). The pathologic features of renal changes 
in these groups were similar and will be described together. All glo-
meruli were affected. (Fig 7). The glomeruli were hypercellular with 
swollen endothelial, epithelial and mesangial cells. The capillary lumens 
were narrow and relatively bloodless. (Fig 8, 9). Kidney sections ex-
amined by a perfusion fixation technique revealed swelling and increase 
of mesangial ground substance and cells. The glomerular basement 
membrane appeared thick in the section stained with PAS. Granular 
PAS-positive materials were more numerous in these rats. (FiglO.) In 
some glomeruli, abhesion between glomerular tuft and Bowmann's 
capsule was detected. Lobulation was found frequently. (Fig 9). Protein 
rich eosinophilic colloidal casts were found in the tubular spaces. In 
gross specimen, these kidneys were white and large with a fine granular 
surface, and ascites were noted in four rats. Sections from group III 
(1) d indicated sclerosing of the capillary tuft at the vascular pole. 
(Fig 11). There werc few pathognomon.ic alterations in the sections 
from the kidneys of groups III (1) a and b. (Fig 5,6) 
                   DISCUSSION 
   An experimental lesion resembling human nephrosis has been prod-
uced in rats by subcutaneous injection of an aminonucleoside, 6-dime-
thylamino, 3-amino-ribose. "114) 
   Increased urinary protein excretion has been noted in the experi-
mental animals by the 5th day after injections of AN and the degree 
of proteinuria increased progressively, reaching a peak on the 15th day. 151 
   In this study, rats received daily injections of AN, 0.3 ml. of 0.5 
per cent solution per 100 gm. of body weight. Urinary protein was 
estimated by dipping the end of an Albustix and comparing the color 
with six color standards. By the 3rd day of AN treatment urinary protein 
was (±) to (+), by the 7th day (+) to (+ +). These results appeared 
to be similar to the observations made by other reporters. When kidney 
sections from AN treated rats were examined by light microscopy, no 
detectable glomerular lesions were identified in the early and reversible
stage of injury (within 7 days). 
   According to other studies, electron microscopic examination of the 
glomeruli from rats treated with AN has revealed definite abnor-
malities of the epithelial cells.""" 
   Serial studies of this lesion have indicated that the earliest change 
was a swelling and coalescence of the foot processes beginning on the 
7th day after injection of AN. In addition, large vacuoles containing 
granular material, similar in appearance to precipitated protein, were 
observed inside the cytoplasm of epithelial cells of the nephrotic rats. 
HARKIN reported that this granular material was the same as the PAS-
positive material found in light microscopic examination. At the present 
time these materials have been interpreted as morphologic appearsnce 
of accelerated transport of serum protein. 171 
   In the present study the rats received intravenous injections of 
homologous or heterologous soluble antigen-antibody complexes in an-
tigen excess by the time they indicated the early postproteinuric state 
(i.e., increased permeability of protein from glomerular basement 
membrane). Only minimal morphological changes were found. 
   Experimental serum sickness has been extensively investigated 
since RICH & GREGORY, intravenously injected a large amount of horse 
serum in rabbits. 1)2)3)4) 
    HAWN et al."' and others"' 20)21)22)23), employing purified antigens, 
have shown lesions similar to those RICH & GREGORY reported prolife-
rative glomerulonephritis and lesions similar to those seen in polyar-
teritis nodosa and rheumatic disease. 
    GERMUTH et al., interpreting the immunologic events5' as related 
to morphologic alterations, stated that the lesions developed during the 
immune phase of antigen elimination and that the morphologic lesions 
of serum sickness were the result of an antigen-antibody reaction. It has 
been repeatedly demonstrated that this reaction occurred as the host 
began to form antibody while antigen was still in circulatcon and in the 
tissues. In these observations, it has been apparent that the develo-
pment of serum sickness occurs at the time of antigen-antibody interac-
tion. More direct support for the role of soluble antigen-antibody compl-
exes in the pathogenesis of serum sickness was supplied by the study 
Of MCCLUSKY et al. 11)1.2) , which showed that the intravenous injections 
of large amount of soluble antigen-antibody complexes produced the 
characteristic lesions of serum sickness in normal mice. They explained 
how these complexes were arrested in the tissue affected by the serum 
sickness, that antigen-antibody complexes had been in circulation as 
unstable colloidal particles, that they were readily phagocytized by the 
cells of the reticuloendothelial system and such colloidal particles could 
be localized in glomeruli and vascular endothelium in various organs 
under the influence of agents such as histamine, knov.-n to be released 
by antigen-antibody complexes, For these reasons it was postulated
that in serum sickness antigen-antibody complexes produced changes 
in the endothelium of glomeruli and blood vessels by releasing subs-
tances such as histamine. The alteration thus induced leads to the 
arrest of the complexes in these sites and, in turn, to the tissue 
damage. 
   MCCLUSKY reported that it required at least 12.5 mg. antibody 
protein per 100 gm. of body weight to produce the lesions of serum 
sickness. 
    ISHIZAKA et al. , GERMUTH et al. al. and TREANIN to al. reported 
that soluble antigen-antibody complexes in antigen excess have biological 
activity which does not have antigen or antibody alone, but also inclu-
des heavy (-Ag3 Ab2)24' and light (Ag2 Ab) complexes, the former 
being more active biologically. 25' 
   Antigen excess immune complexes prepared from heterologous or 
homologous antibody have produced (1) anaphylactic shock when injected 
into normal unsensitized gunea pigs6"' and mice, 8' (2) contraction of 
isolated gunea pig smooth muscles, 9' and (3) passive skin reactions in 
gunea pigs.10' Large, multiple doses cause transient acute proliferative 
glomerulonephritis in mice. 111121 
   MCCLUSKY et al.26' produced experemental glomerulonephritis in 
mice employing two kinds of soluble complexes, crystallized ovalbumin 
anti-ovalbumin rabbit antiserum system and crystallized bovine serum 
albumin .. anti-bovine serum albumin rabbit antiserum system, They 
stated that the former was more effective for development of the dis-
ease than the latter. They concluded that the difference in excretion 
of these two antigen might be a contributory factor in the greater 
severity of the disease observed with the ovalbumin anti-ovalbumin 
rabbit serum system. 
   C9ONS et al. intravenously injected mice with 3 kinds of protein 
(ovalbumin, bovine serum albumin, and human globulin) and obser-
ved that the disappearance of ovalbumin from the kidney was fast and 
that of human ~--globulin was Slow. 27' Their differing rates of disappe-
arance are partly due to the relative ease with which they pass through 
the glomerular filter.28' 
   In consideration of these events and the biological activity of imm-
une soluble complexes, it appears that soluble complexes of low mole-
cular systems are more complex at the site of glommerular filter, and 
thus, biologically active complexes such as -Ag3Ab2 become numerous 
in a short time. 
   On the other hand, it has been considered that the affiniating or 
combining ability of injected protein with tissues is an important factor 
contributing to some hypersensitive states. 
   MILLER produced experimental glomerulonephritis in mice by intra-
venous injection of heterologous (ovalbumin anti-ovalbumin rabbit serum 
system) and homologous (ovalbumin anti-ovalbumin mouse serum system"
immune soluble complexes. 29) He reported that the lesions of the mice 
which received homologous complexes were more severe. 
    In the present study, rats received homologous or heterologous 
soluble complexes intravenously by the time they indicated urine with 
low protein content by aminonucleoside treatment and they were exa-
mined histologically and immunologically. 
   The dose of the soluble complexes injected in this study was stan-
dardized at 3 ml. of 10 mg. protein in 1 ml., a total 30 mg. of protein. 
This ranged from 1, mg. to 2mg. of antibody protein in terms of anti-
body protein per 100gm. of rat body weight. It is not necessary to inject 
such large amount to produce glomerulonephritis, if the rats had rece-
ived aminonucleoside in advance. The glomerular basement membrane 
has been considered the main filter for filtration of serum protein in 
the normal kidney. Experimental diseases, such as aminonucleoside 
nephrosis, increased ferritin uptake in glomerular basement membrane 
and glomerular epithelial cells.30) 
   Protein is filtered more rapidly into urine, when the permeability 
of the glomerular basement membrane is increased by the aminonu-
cleoside treatment. In addition to the effect of aminonucleoside, immune 
soluble complexes may possibly cause an increase in the permeability. 
   The results of the immunoelectropholetic examination in this study 
are indirect support for this hypothesis. In urine with a high protein 
content, the presence of BSA, a component of soluble complexes, was 
detected immunologically. In addition, multiple reaction lines were found 
between urine specimens and anti-rat serum rabbit antiserum, but only 
a few such lines were found between anti-rat antibody and urine speci-
mens with a low protein content. 
   Thus, it is possible that under these circumstances biologically 
active soluble complexes (-Ag3Ab2) are accumulated in great quantities, 
in a short time, at the site of glomerular filter membrane. 
   This hypothesis leads to the consideration that these biologically 
active complexes play an important role in the pathogenesis of experi-
mental glomerulonephritis. 
   The characteristic findings of acute proliferative glomerulonephritis 
(hypercellularity, ischemia and swelling of glomeruli), appear to be 
caused by irritation by biologically active immune complexes, whereas 
these changes have not been seen in aminonucleoside nephrosis. 
   It could not be determined by the present study whether soluble 
complexes themselves or complexes and chemical agents together played 
a major part in the histogenetic effect. (Chemical agents, such as 
histamine, are believed to be released by immune complexes) 
   The role of affinity or combination ability of protein to tissue also 
needs to be clarified by further study. 
   In the present experimental disease, I could not find other lesions
such as arteritis or endocarditis which were reported by MCCLUSKY et 
al. and others. I suspect that smaller amounts of soluble comlexes used 
for the injections in my experiment may cause this difference. 
   Comparing the present experimental glomerulonephritis with human 
poststreptococcal glomerulonephritis, the mechanism in the development 
of human glomerulonephritis would be as follows: In the first phase, 
a toxin, such as streptococcal toxin, causes an increase in the perme-
ability of glomerular basement membrane. Indirect support for this 
suggestion is fibrile proteinuria clinically observed. In the second 
phase, biologically active soluble antigen-antibody complexes, such as 
-Ag3Ab2 , accumulate in great quantities in a short time at the site of 
glomerular basement membrane which was damaged in the first phase, 
and then glomerulonephritic lesions develop with hypercellularity, 
ischemia and swelling of glomeruli. 
   This hypothesis appears to be suported by the present experimental 
findings: Aminonucleoside treatment coincides with the first phase, 
and injetion of soluble complexes coincides with the second phase. 
   Diffuse glomerulonephritis can be divided into two main groups31', 
the nephritic type and the nephrotic type. The nephritic type mainly 
affects children and young adults and it is commonly a sequela of 
acute tonsillar or pharyngeal infections with group A streptococci 
associated with acute onset. Heanaturia, pyuria and hypertension are 
often associated with acute cases of nephritic glomerulonephritis. Com-
plete recovery is common. The glomerular lesions in the acute stage 
are mainly proliferative, exudative or hemorrhagic and occasionally 
necrotizing. 
   The nephrotic type, on the other hand, affects a wider age group 
and a history of a preceding infection is rarely elicited. The onset is 
insidious; nephrotic symptoms (protracted proteinuria, edema, ascites, 
hypoproteinemia and hyperlipemia) are prominent; histologically thi-
ckening of basement membrane and lobulation are commonly seen. 
However, as ALLEN and others"' emphasized, there are frequent tran-
sitions between these two types. Whether the pathogenesis of these 
two types of glomerulonephritis is the same or not, is an interesting 
question. 
   The present experimental glomerulonephritis is a mixed type: 
Hypertension (which is suspected because of the increased heart 
weight), and histologic findings of the kidney (hypercellularity, ische-
mia, and swelling of glomeruli), indicate the nephritic type of glom-
erulonephritis, but severe proteinuria, ascites (observed in some rats), 
lobulation, and glomerular basement membrane thickening indicate the 
nephrotic type of glomerulonephritis. 
   It has been considered that the autoimmune mechanism plays an 
important role in chronic evolution of glomerulonephritis. In this study 
chronic evolution of the disease was not discussed,
   Two rats which received an injection of soluble complexes every 3 
days for a total of 7 injections over a period of 24 days, indicated 
interesting lesions leading to chronic glomerulonephritis. The present 
study, however, does not settle the question what role the autoimmune 
mechanism or repeated irritation of exogenous soluble complexes or 
both played as a cause of the lesions. 
                    SUMMARY
   Experimental glomerulonephritis was produced in rats by admini-
stration of aminonucleoside for 6 to 7 days followed by 3 intravenous 
injections of homologous or heterologous soluble complexes in antigen 
excess with a 12-hour interval between each injection. 
   This experimental model supplies several forms of evidence leading 
to a hypothesis on the pathogenesis of human glomerulonephritis. 
(1) Smaller amounts of soluble complexes than reported by others were 
  sufficient to cause glomerulonephritis in rats if previously treated 
  with amino nucleoside. 
(2) Histologically, this type of glomerulonephritis is a mixed type. 
(3) Severe proteinuria was noted in this glomerulonephritis, and BSA, 
  a component of soluble complexes, was demonstrated immunologi-
  cally in the urine with a high protein content, whereas it was not 
  present or noted in only trace amounts in the urine with a low 
  protein content. 
(4) This appears to be indirect support for the hypothesis that biolo-
  gically active complexes accumulate in great quantities in a short 
  time at the site of glomerular filter membrane. 
(5) These complexes appear to be an important factor in the develo-
  pment of characteristic glomerulonephritic changes, hypercellularity, 
  ischemia and swelling of glomeruli. 
(6) The increased permeability of glomerular basement membrane 
  represents the first phase of the development of glomerulonephritis 
  in man and irritation of biologically active complexes at the site of 
  the glomerular filtermembrane represent the second phase. The first 
  phase coincides with AN treatment, and the second phase coincides 
  with cinjection of soluble complexes as demonstrated in this study. 
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Fig. 2: Photograph (left) and diagram (right) of immunoelectropholesis of urine 
       specimen indicating severe proteinuria. They show four reaction lines between 
       anti-rat serum rabbit antibody and one line between anti-BSA rabbit antibody.
Fig. 3: Photograph (left) and diagram (right) of immunoelectropholesis of urine 
       specimen indicating low grade protein urea. They show only one line between 
       the urine specimen and rabbit serum containing anti-rat antibody.
Fig. 4: Kidney of a rat which was treated 
       with AN for 7 days. Glomeruli are 
       almost normal. PAS stain, low magni-
       fication.
Fig. 5: Glomerulus of a rat which received ho-
       mologous soluble complexes every 12
       hours for 3 injections. No detectable
       change is seen. Perfusion fixation with 
       glutalaldeheide, PAS stain, high ma-
       gnification.
Fig. 6: Glomerulus from a rat which received 
       homologous complexes after AN trea-
       tment for 2 days. It shows almost
       normal structure. Perfusion fixation, 
      PAS stain, high magnification.
Fig. 7: Kidney from a rat which received 
       heterologous complexes after AN treat-
       ment for 7 days. Swelling of glome-
       ruli, hypercellularity and ischemia ap-
       pear. These lesions are noted in all
       glomeruli. PAS stain, low magnisi-
       cation.
Fig. 8: Glomerulus from a rat which received 
       homologous complexes after AN treat-
       ment for 7 days. It shows hypercellular,
       relatively bloodless glorrierulus. PAS 
       stain, high magnification.
Fig. 9: Photomicrography from same section 
       illustrated Fig. 7. Hypercellularity, 
       relatively bloodless, in addition, lobu-
       lation is observed in this glomerulus.
      PAS stain, high magnification.
Fig. 10: Glomerulus from a rat which received 
       homologous complexes after AN trea-
       tment for 6 days. Adhesion between 
       loops, thickening of basement membrane 
       is seen. Perfusion fixation, PAS stain, 
      high magnification.
Fig.11: Glomerulus from a rat which received 
       homologous complexes every 3 days for 
       7 injections after AN treatment for 7 
      days. PAS possitive, sclerosing lesion 
      is observed. PAS stain, highmagnifi-
       cation.
